A Clinical Lipidomics Platform: Development and Validation of a High-Throughput LC-MS Assay for Cardiovascular Disease Risk Assessment

Journal:

Analytical Chemistry

Published:

2026-03-27

DOI:

10.1021/acs.analchem.5c04984

Affiliations:

9

Authors:

23

Go to article

Institutions	Authors	Share
Baker Heart and Diabetes Institute (Baker IDI), Australia	10.250000 10.250000	0.45
Trajan Scientific and Medical, Australia	3.000000	0.13
Kolling Institute, Australia	3.000000	0.13
The University of Melbourne (UniMelb), Australia	2.250000	0.10
La Trobe University, Australia	1.750000	0.08
The University of Sydney (USYD), Australia	1.000000	0.04
Royal Prince Alfred Hospital (RPAH), USYD, Australia	1.000000	0.04
Monash University, Australia	0.750000	0.03

Interested in Bioinformatics and Computational Biology?